PRIYA HIPPOLYTE: Open Payments
NPI 1124592324 · MILTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 16 payments from 6 companies in 2025. Trend: 2023 $220 · 2024 $698 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $277 |
| Axsome Therapeutics, Inc. | 4 | $233 |
| Otsuka America Pharmaceutical, Inc. | 4 | $194 |
| E.R. Squibb & Sons, L.L.C. | 1 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $36 |
| Sage Therapeutics, LLC | 1 | $28 |
Products named: CAPLYTA, Auvelity, REXULTI, COBENFY, SPRAVATO, ZURZUVAE.
Industry payments across MA — which companies pay providers there.
